| Early detection and staging of chronic liver diseases with a protein MRI contrast agent M Salarian, RC Turaga, S Xue, M Nezafati, K Hekmatyar, J Qiao, Y Zhang, ... Nature communications 10 (1), 4777, 2019 | 57 | 2019 |
| Prostate-specific membrane antigen targeted protein contrast agents for molecular imaging of prostate cancer by MRI F Pu, M Salarian, S Xue, J Qiao, J Feng, S Tan, A Patel, X Li, K Mamouni, ... Nanoscale 8 (25), 12668-12682, 2016 | 45 | 2016 |
| Precision detection of liver metastasis by collagen-targeted protein MRI contrast agent M Salarian, H Yang, RC Turaga, S Tan, J Qiao, S Xue, Z Gui, G Peng, ... Biomaterials 224, 119478, 2019 | 29 | 2019 |
| Chemokine receptor 4 targeted protein MRI contrast agent for early detection of liver metastases S Tan, H Yang, S Xue, J Qiao, M Salarian, K Hekmatyar, Y Meng, ... Science advances 6 (6), eaav7504, 2020 | 20 | 2020 |
| Early detection and staging of lung fibrosis enabled by collagen-targeted MRI protein contrast agent OY Ibhagui, D Li, H Han, G Peng, ML Meister, Z Gui, J Qiao, M Salarian, ... Chemical & Biomedical Imaging 1 (3), 268-285, 2023 | 4 | 2023 |
| Non-invasive detection and complementary diagnosis of liver metastases via chemokine receptor 4 imaging H Yang, S Tan, J Qiao, Y Xu, Z Gui, Y Meng, B Dong, G Peng, OY Ibhagui, ... Cancer gene therapy 29 (12), 1827-1839, 2022 | 4 | 2022 |
| VEGF overexpression significantly increases nanoparticle-mediated siRNA delivery and target-gene downregulation S Tan, Z Chen, Y Mironchik, N Mori, MF Penet, G Si, B Krishnamachary, ... Pharmaceutics 14 (6), 1260, 2022 | 4 | 2022 |
| Protein MRI contrast agents as an effective approach for precision molecular imaging D Li, M Kirberger, J Qiao, Z Gui, S Xue, F Pu, J Jiang, Y Xu, S Tan, ... Investigative Radiology 59 (2), 170-186, 2024 | 2 | 2024 |
| Targeted protein contrast agents, methods of making, and uses thereof JJ Yang, PU Fan, S Xue, J Qiao, M Salarian, S Tan US Patent 10,814,020, 2020 | 2 | 2020 |
| Targeted protein contrast agents, methods of making, and uses thereof JJ Yang, PU Fan, S Xue, J Qiao, S Tan, M Salarian US Patent App. 17/819,180, 2023 | | 2023 |
| Targeted protein contrast agents, methods of making, and uses thereof JJ Yang, PU Fan, S Xue, J Qiao, S Tan, M Salarian US Patent 11,426,471, 2022 | | 2022 |
| Targeted protein contrast agents, methods of making, and uses thereof JJ Yang, PU Fan, S Xue, J Qiao, S Tan, M Salarian US Patent 11,419,954, 2022 | | 2022 |
| EARLY DETECTION, STAGING, AND MONITORING TREATMENT OF LIVER DISEASES BY PRECISION MRI (PMRI) ENABLED BY BIOMARKER TARGETED PROTEIN MRI CONTRAST AGENTS OY Ibhagui, Z Gui, M Salarian, J Qiao, H Yang, S Tan, D Li, J Yang HEPATOLOGY 74, 345A-346A, 2021 | | 2021 |
| Precision MRI Enabled by Protein MRI Contrast Agents M Salarian, S Tan, OY Ibhagui, J Qiao, Z Gui, JJ Yang INVESTIGATIVE RADIOLOGY 54 (12), 795-795, 2019 | | 2019 |
| Development of Chemokine Receptor 4 Targeted MRI Contrast Agent for the Precision MRI Imaging of Cancer and Metastasis S Tan | | 2019 |
| CXCR4 expression in an intraocular melanoma mouse model with hepatic metastases H Yang, H (Yang, S Tan, SS (Tan, HE Grossniklaus, HE (Grossniklaus, ... INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 58 (8), 2017 | | 2017 |
| VEGF overexpression in breast cancer xenograft significantly increases nanoparticle-mediated siRNA delivery and target gene downregulation S Tan, Z Chen, Y Mironchik, N Mori, MF Penet, B Krishnamachary, ... | | |
| Precision MRI (pMRI) of Liver Metastasis enabled by Protein MRI contrast agents J Yang, M Salarian, H Yang, S Tan, OY Ibhagui, J Qiao, Z Gui, ... | | |
| Protein MRI Contrast Agents (ProCAs) with Unique Capability in Early detection and Molecular Imaging of Varies Types of Cancer J Yang, J Qiao, S Xue, F Pu, S Tan, J Jiang, A Patel, Z Liu | | |
Jingjuan QiaoGeorgia State UniversityVerified email at gsu.edu
